EUVIMEDEUVIMED entdecken
Crossref

L26/P-794 IUI, IVF, or PGT-A: which treatment achieves live birth sooner in unexplained infertility? An age-stratified analysis of 2,065 cycles

J. Khalifeh, S. Rasaily, A. Mania, K. Nicolaides, A. Capalbo, S. Sunkara, Y. Beebeejaun

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von J. Khalifeh und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Among women with unexplained infertility, which treatment— IUI, IVF, or PGT-A—achieves live birth sooner across different age groups? Summary answer PGT-A achieved the shortest time to live birth across age groups, while IVF demonstrated age-dependent benefit compared with IUI in unexplained infertility. What is known already In unexplained infertility, initial treatment commonly involves intrauterine insemination (IUI) due to its lower invasiveness and cost, with escalation to in vitro fertilisation (IVF) when IUI fails or prognosis worsens. Pre-implantation genetic testing for aneuploidy (PGT-A) is frequently introduced after IVF failure or when patients transition into older age groups. Existing evidence largely focuses on per-cycle pregnancy or live birth rates, which do not capture treatment efficiency or cumulative patient experience. Time to live birth (TTLB) has therefore been proposed as a more patient-centered outcome, yet comparative time-to-event data across IUI, IVF, and PGT-A, particularly stratified by age, remain limited. Study design, size, duration This retrospective cohort study included women undergoing fertility treatment for unexplained infertility between 2017 and 2025 at a single tertiary fertility centre. Where multiple treatment modalities were undertaken, hierarchical escalation pathways were mapped and the index cycle was defined as the first eligible treatment; each patient was included once. Treatment exposure comprised up to three IUI/embryo transfer attempts with censoring if embryos were exhausted. Participants/materials, setting, methods 1,020 unique patients contributing 2,065 treatment cycles were included. Time-to-event analyses used treatment attempt number as the time scale, with live birth as the event of interest, and follow-up continued until live birth or censoring. Analyses were performed using STATA 19, Kaplan–Meier curves, and age-stratified Cox models. Live birth rates were presented as odds ratios (OR), time to live birth as hazard ratios (HR), with age-standardized inverse probability weighting as sensitivity analysis. Main results and the role of chance Across the entire cohort, LBR were 25.7% for IUI, 37.2% for IVF, and 58.2% for PGT-A. Compared with IUI, the odds of live birth were significantly higher following IVF (OR 1.72,95% CI:1.29–2.29; p=0.0003) and PGT-A (OR 4.03,95%CI:2.75–5.92; p<10−¹²). PGT-A was also associated with significantly higher odds of live birth compared with IVF (OR 2.35,95% CI:1.59–3.47;p<0.0001). When stratified by age, Cox analyses demonstrated differences in TTLB. In women aged ≤35 years, both IVF (HR 1.38,95% CI:1.00–1.91;p=0.049) and PGT-A (HR 2.45, 95% CI:1.52–3.95;p<0.001) were associated with shorter TTLB compared with IUI, with PGT-A superior to IVF (HR 1.77,95% CI:1.08–2.90;p=0.023). Among women aged 35–39 years, IVF was not associated with a statistically significant difference in TTLB compared with IUI (HR 1.38,95% CI:0.92–2.05;p =0.117), whereas PGT-A was associated with shorter TTLB compared with both IUI (HR 2.59, 95% CI:1.60–4.19;p< 0.001) and IVF (HR 1.88, 95% CI:1.20–2.96;p=0.006). In women aged ≥40 years, both IVF (HR 3.75,95% CI:1.39–10.11;p=0.009) and PGT-A (HR 6.71, 95% CI:2.63–17.09;p<0.001) were associated with shorter TTLB compared with IUI, with PGT-A remaining superior to IVF (HR 1.79,95% CI:1.01–3.15;p=0.045). Kaplan–Meier curves demonstrated consistent early and sustained separation across age groups. Limitations, reasons for caution Residual confounding is likely, as adjustment and propensity weighting were restricted primarily to age, and treatment allocation reflected clinical decision-making. Wider implications of the findings These findings highlight the relevance of time to live birth as a patient-centered outcome in unexplained infertility. Age-stratified survival analyses may inform counselling and treatment sequencing and support future prospective studies incorporating broader prognostic variables to guide individualized decision-making. Trial registration number No

Zitieren

APA

Khalifeh, J., Rasaily, S., Mania, A., Nicolaides, K., Capalbo, A., Sunkara, S., & Beebeejaun, Y. (2026). L26/P-794 IUI, IVF, or PGT-A: which treatment achieves live birth sooner in unexplained infertility? An age-stratified analysis of 2,065 cycles. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1121

Vancouver

Khalifeh J, Rasaily S, Mania A, Nicolaides K, Capalbo A, Sunkara S, et al. L26/P-794 IUI, IVF, or PGT-A: which treatment achieves live birth sooner in unexplained infertility? An age-stratified analysis of 2,065 cycles. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1121

BibTeX
@article{Khalifeh2026,
  author = {Khalifeh, J. and Rasaily, S. and Mania, A. and Nicolaides, K. and Capalbo, A. and Sunkara, S. and Beebeejaun, Y.},
  title = {L26/P-794 IUI, IVF, or PGT-A: which treatment achieves live birth sooner in unexplained infertility? An age-stratified analysis of 2,065 cycles},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1121}
}
Kostenlos starten →